Literature DB >> 28661221

Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis.

Usha Ranganathan1, Ulrike Kaunzner1, Stacyann Foster1, Timothy Vartanian1, Jai S Perumal1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28661221     DOI: 10.1177/1352458517719152

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  1 in total

1.  Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenon.

Authors:  Marco Puthenparampil; Francesca Rinaldi; Lisa Federle; Chiara Cazzola; Paola Perini; Paolo Gallo
Journal:  Ther Adv Neurol Disord       Date:  2017-11-29       Impact factor: 6.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.